1. Home
  2. BHVN vs NHC Comparison

BHVN vs NHC Comparison

Compare BHVN & NHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • NHC
  • Stock Information
  • Founded
  • BHVN 2013
  • NHC 1971
  • Country
  • BHVN United States
  • NHC United States
  • Employees
  • BHVN N/A
  • NHC N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • NHC Hospital/Nursing Management
  • Sector
  • BHVN Health Care
  • NHC Health Care
  • Exchange
  • BHVN Nasdaq
  • NHC Nasdaq
  • Market Cap
  • BHVN 1.9B
  • NHC 1.6B
  • IPO Year
  • BHVN 2017
  • NHC N/A
  • Fundamental
  • Price
  • BHVN $14.63
  • NHC $108.44
  • Analyst Decision
  • BHVN Strong Buy
  • NHC
  • Analyst Count
  • BHVN 14
  • NHC 0
  • Target Price
  • BHVN $58.85
  • NHC N/A
  • AVG Volume (30 Days)
  • BHVN 2.0M
  • NHC 86.5K
  • Earning Date
  • BHVN 08-07-2025
  • NHC 08-08-2025
  • Dividend Yield
  • BHVN N/A
  • NHC 2.36%
  • EPS Growth
  • BHVN N/A
  • NHC 31.05
  • EPS
  • BHVN N/A
  • NHC 6.91
  • Revenue
  • BHVN N/A
  • NHC $1,374,458,000.00
  • Revenue This Year
  • BHVN $3.00
  • NHC N/A
  • Revenue Next Year
  • BHVN $59.97
  • NHC N/A
  • P/E Ratio
  • BHVN N/A
  • NHC $15.69
  • Revenue Growth
  • BHVN N/A
  • NHC 18.19
  • 52 Week Low
  • BHVN $13.87
  • NHC $89.14
  • 52 Week High
  • BHVN $55.70
  • NHC $138.49
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 41.97
  • NHC 61.93
  • Support Level
  • BHVN $14.00
  • NHC $106.35
  • Resistance Level
  • BHVN $15.09
  • NHC $109.68
  • Average True Range (ATR)
  • BHVN 0.73
  • NHC 2.82
  • MACD
  • BHVN 0.13
  • NHC 0.12
  • Stochastic Oscillator
  • BHVN 41.44
  • NHC 90.58

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About NHC National HealthCare Corporation

National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.

Share on Social Networks: